Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation

Journal of Dermatology

Volumn 32, Issue 4, 2005, Pages 278-281

  Sekiguchi, Atsushi ^a   Kashiwagi, Takayuki ^a   Ishida Yamamoto, Akemi ^a   Takahashi, Hidetoshi ^a   Hashimoto, Yoshio ^a   Kimura, Hiroshi ^b   Tohyama, Mikiko ^c   Hashimoto, Koji ^c   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytomagalovirus; Drug induced hypersensitivity syndrome; Human herpes virus 6 (HHV 6)

Indexed keywords

CORTICOSTEROID; CYTOMEGALOVIRUS ANTIBODY; MEXILETINE; PREDNISOLONE; VIRUS ANTIBODY; VIRUS DNA;

ACUTE HEART INFARCTION; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEATH; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HYPERSENSITIVITY SYNDROME; DRUG WITHDRAWAL; ERYTHEMA; FEVER; GENERAL CONDITION IMPROVEMENT; HEART VENTRICLE TACHYCARDIA; HERPES; HUMAN; HUMAN HERPESVIRUS 6; LEUKOCYTOSIS; LIVER DYSFUNCTION; LYMPHOCYTE; MALE; MYOCARDITIS; PRURITUS; RASH; RECURRENT DISEASE; SYMPTOM; VIRUS REACTIVATION;

EID: 19744380887     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00762.x     Document Type: Article

References (15)

1. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T: Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome, Arch Dermatol, 134: 1108-1112, 1998.
2. Tohyama M, Yahata Y, Yasukawa M, et al: Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6, Arch Dermatol, 134: 1113-1137, 1998.
3. Descamps V, Valance A, Edlinger C, et al: Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms, Arch Dermatol, 137: 301-304, 2001.
4. Sullivan JR, Shear NH: The drug hypersensitivity syndrome: what is the pathogenesis?, Arch Dermatol, 137: 357-364, 2001.
5. Descamps V, Collot S, Mahe E, Houhou N, Crickx B, Ranger-Rogez S: Active human herpes virus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms, J Invest Dermatol, 121: 215-216, 2003.
6. Descamps V, Bouscarat F, Laglenne S, et al: Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome, Br J Dermatol, 137: 605-608, 1997.
7. Arakawa M, Kakuto Y, Ichikawa K, Chiba J, Tabata N, Sasaki Y: Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia, Int Med, 40: 331-335, 2001.
8. Aihara M, Sugita Y, Takahashi S, et al: Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus, Br J Dermatol, 144: 1232-1234, 2001.
9. Regnier S, Descamps V, Boui M, et al: Parvovirus B19 infection mimicking drug-induced hypersensitivity syndrome [French], Annales de Dermatologie Venereologie, 127: 505-506, 2000.
10. Descamps V, Mahe E, Houhou N, et al: Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection, Br J Dermatol, 148: 1032-1034, 2003.
11. Pankuweit S, Portig I, Eckhardt H, Crombach M, Hufnagel G, Maisch B: Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease, Herz, 25: 221-226, 2000.
12. de la Hoz RE, Stephens G, Sherlock C: Diagnosis and treatment approaches of CMV infections in adult patients, J Clin Virol, 25 (Suppl 2): s1-s12, 2002.
13. Baumal CR, Levin AV, Read SE: Cytomegalovirus retinitis in immunosuppressed children, Am J Ophthalmol, 127: 550-558, 1999.
14. Glowacki LS, Smaill FM: Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients-A meta-analysis, Clin Transplant, 8: 10-18, 1994.
15. Roujeau JC: Treatment of severe drug eruptions, J Dermatol, 26: 718-722, 1999.